предыдущая
к содержанию
следующая

Литература

  1. Багманова З.А., Мазур Н.А. Аритмогенная дисплазия правого желудочка: современные представления об этиологии, патогенезе, течении, диагностике, прогнозе и лечении / / Кардиология. - 1995. - № 6. - С. 72-77.
  2. Мазур Н.А. Пароксизмальные тахикардии. М.: Медицина, 1984. - 189 с.
  3. Мазур Н.А. Внезапная смерть больных ишемической болезнью. М.: Медицина, 1985. - 189 с.
  4. Мазур Н.А. Очерки клинической кардиологии. М.: МИА, 1999. - 255 с.
  5. Мазур Н.А. (ред.) Внезапная сердечная смерть. - М.: Медпрактика, 2003. - 148 с.
  6. Мазур Н.А., Абдалла А. Фармакотерапия аритмий. М.: Оверлей, 1995. - 222 с.
  7. Мазур Н.А., Назаров Э.А., Титов В.Н. Вазодилататоры и содержание катехоламинов в плазме крови у больных умеренной артериальной гипертонией // Кардиология. - 1992.
  • 32. - № 7-8. - С. 10-12.
  1. Чигинева В.В. Сравнительная оценка эффективности медикаментозных средств и влияние двухкамерной электрокардиостимуляции на клинико-гемодинамические показатели у больных гипертрофической кардиомиопатией: Автореф. канд. диссертации. - 1997 г.
  2. ACC/AHA/ESC guideLiness for the management of patients with supraventricular arrhythmias
  • executive summary // Eur. Heart J. - 2003. - 24, 20. - P. 1857-1897.
  1. Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology / / Eur. Heart J. - 1996. - 17. - P. 43-63.
  2. Albert C.M., Hennekens C.H., O'Donnell C.J. et al. Fish consumption and risk of Sudden Cardiac Death // JAMA. - 1998. - 279. - P. 23-28.
  3. Aliot E., de Chillou C., Revault D'Allones G. Mahaim tachycardias // Eur. Heart J. - 1998.
  • suppl. E. - P. 25-31.
  1. Antzelevitch C. The Brugada syndrome: diagnostic criteria and cellular mechanisms // Eur. Heart J. - 2001. - 22, 5. - P. 356-363.
  2. Bayes D.L, Coumel P., Leclercq J.F. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases // Am. Heart J. - 1989.
  • 117. - P. 151-159.
  1. Bettini R., Durante G.B., Vergara G. et al. Arrhythmogenic right ventricular disease: natural hystory and prognostic implication in a case study of 39 patients. New Trends//Arrhythmia.
  • 1988. - № 4. - P. 397-401.
  1. Bigger J.T. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators // N Engl J. Med. - 1997. - 337. - P. 1569-1575.
  2. Brugada J., Brugada R., Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demenstrable structural heart disease // Circulation. - 1998. - 97. - P. 457-460.
  3. Brugada K., Hong K., Dumaine R. et al. Sudden death associated with Short - QT syndrome linked to mutations in HERG // Circulation. - 2004. - 109, 1. - P. 30-35.
  4. Campbell R.W.F. Atrial fibrillation // Eur. Heart 3. - 1998. - suppl. E. - P. 41-45.
  5. Campbell R.W.F. Atrial flutter // Eur. Heart 3. - 1998. - suppl. E. - P. 37-40.
  6. Camm A.3., Janse M.3., Roden D.M. et a I. Congenital and acquired long QT syndrome // Eur. Heart J. - 2000. - V. 21, 15. - P. 1232-1237.
  7. Cardenas F., Gonzalez R., Fajuri A. et al. Arrhythmogenic dysplasia of the right ventricule: clinical presentation and longterm course // Rev. Med. Chil. - 1992. - Vol. 120, № 6. - P. 627-633.
  8. Corrado D. et al. Sudden death in young people with apparently isolated mitral valve prolapse // G. Ital. Cardiol. - 1997. - 27. - P. 1097-1105.
  9. Corrado G., Sgalambro A., Mantero A. et al. Thromboembolic risk in atrial flutter; the FLASIEC (Flutter atriale Societa italiana di Ecografia Cardiovascolare) multicentre study / / Eur. Heart 3. - 2001. - 22, 12. - P. 1042-1051.
  10. Coumel P., Thomas 0., Leenhardt A. Drug therapy for prevention of atrial fibrillation // Am. 3. Cardiol. - 1996. - 77. - P. 3a-9a.
  11. De Paola A.A., Horowitz L.N., Margues F.B. etal. Control of multiform ventricular tachycardia by propranolol in a child with no identifiable cardiac disease and sudden death // Am. Heart
  1. - 1990. - 119. - P. 1429-1432.
  1. Dorostkar P.C., Eldar М., Bellhassen B., Scheinman M.M. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing // Circulation.
  • 1999. - 100. - P. 2431-2436.
  1. Elliott P.M., Poloniecki 3., Dickie S. at al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients // 3. Am. Coll. Cardiol. - 2000. - 36. - P. 2212-2218.
  2. Feinberg W.M. et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implication // Arch, intern, med. - 1995. - 155. - P. 469-473.
  3. Freed L.A., Levy D., Levine R.A. et al. Prevalence and clinical outcome of mitral valve prolapse // N. Engl. 3. Med. - 1999. - 341. - P. 1-7.
  4. Frustaci A. et al. Histological substrat of atrial biopsies in patients with lone atrial fibrillation // Circulation. - 1997. - 96. - P. 1180-1184.
  5. Gaita F., Guistetto C., Bianchi F. et al. Short - QT syndrome: a familial case of sudden death // Circulation. - 2003, 108, 8. - P. 965-970.
  6. Goudevenos 3.A., Katsouras C.S., Graekas G. et al. Ventricular pre-excitationin in the general population: a study on the mode of presentation and clinical course // Heart. - 2000. - 83. - P. 29-34.
  7. Haverkamp W., Martinez R.A., Hiet C. et al. Efficacy and safety of d, I - sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest // 3. Am. Coll. Cardiol. - 1997. - V. 30. - P. 487-495.
  8. Herlitz3., Bahr3., Fischer M. etal. Resuscitation in Europe: a tale of five European regions.
  • 1999. - 41. - P. 121-131.
  1. International 2000 Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: international consensus on science. Resuscitation // 2000. - 46. - P. 1-448.
  2. 3anse M.3., Malik М., Camm A.3., 3ulian D.G., Frangin G.A., Schwartz P.3. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment
    with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial) // Eur. Heart J. - 1998. - 19. - P. 85-95.
  3. Jonven X., Desnos М., Guerot C., Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study // Circulation. - 1999. - 99. - P. 1978-1983.
  4. Kannel W.B., Cupples L.A., D'Agostino R.B., Stokes J. Hypertension, antihypertensive treatment and sudden coronary death. The Framingham Study // Hypertension. - 1988.
  • 11. - P. 1145-1150.
  1. Kjekshus J. Arrhythmias and mortality in congestive heart failure // Am. J. Cardiol. - 1990.
  • 65. - P. 421-481.
  1. Klein A.L. et al. Use of transesophagel echocardiography to guide cardioversion in patients with atrial fibrillation // N. Engl. J. Med. - 2001. - 344. - P. 1411-1420.
  2. La Rovere M.T., Bigger 3.T., Marcus F.L., Mortara A., Schwartz P.3. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators// Lancet.
  • 1998. - 351. - P. 478-484.
  1. Leclercg 3.F., Coumel P. Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia // Eur. Heart 3. - 1989. - Vol. 10, suppl. D. - P. 61-67.
  2. Maggioni A.P., Zuanetti G., Franzosi M.G. et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results // Circulation. - 1993. - 8. - P. 312-322.
  3. Maron B.3. Hypertrophic cardiomyopathy // Lancet. - 1997. - 350. - P. 127-133.
  4. Moss A.3., Hall W.3., Cannom D.S. et al. Improved survival with an implanted defibrillator in patients with coronary disease at high rick for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators // N. Engl. J. Med. - 1997. - 337.
  • P. 1569-1575.
  1. Nava A., Thiene G., Canciani B. et al. Clinical profile of conceald form of arrhythmogenic right ventricular cardiomyopathy presenting with apparently idiopathic ventricular arrhythmia // Int. J. Cardiol. - 1992. - Vol. 35. - P. 195-206.
  2. Nuttal S.L., Toescu V., Kendall M.3. Beta-blockade after myocardial infarction // BM3. - 2000. - 320. - P. 581.
  3. ObelO.A., Camm A.3. Accessory pathway reciprocating tachycardia // Eur. Heart 3. - 1998.
  • 19, suppl. E. - P. 13-24.
  1. Otto C.M., Burwash I.G., Legget M.E. et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome // Circulation. - 1997. - 95. - P. 2762-2770.
  2. Page R.L., Hamdan M.H., Mckenas D.K. Defibrillation a board a commercial aircraft // Circulation. - 1998. - 97. - P. 1429-1430.
  3. Penhkurinen K. et al. Effectiveness of amiodaron as a single oral dose for recent onset atrial fibrillation // Am. 3. Cardiol. - 2000. - 85. - P. 462-465.
  4. Peters N. Clinical developments in cardiac activation mapping // Eur. Heart 3. - 2000. -
  1. 10. - P. 801-807.
  1. Priori S.G., Grotti L. Idiopathic ventricular fibrillation // Cardiac Electrophysiology Rev. - 1999. - 3. - P. 198-201.
  2. Prystowsky E.N. Management of atrial fibrillation: therapeutic options and clinical decisions // Am. J. Cardiol. - 2000. - 85. - P. 3-11.
  3. Saoudy N., Cosio F., Waldo A. et al. A              classification              of atrial              flutter              and              regular              atrial

tachycardia according to electrophysiological mechanisms and anatomical bases; a statement from a jont Expert Group from the working Group of Arrhythmiacs of the ESC and NASPE // Eur. Heart J. - 2001. - 20, 14. - P. 1162-1182.
  1. Schilling R.J., Davies D.W., Peters N.S. Clinical developments in cardiac activation mapping // Eur. Heart J. - 2000. - 21, 10. - P. 801-807.
  2. Schwartz P.J., Priori S.G. Napolitano C. The long QT Syndrome. Cardiac Electrophysiology. From Cell to Bedside. Philadelphia. W.B. Saunders Co. - 2000. - P. 597-615.
  3. Task Force Report. ACC/AHA/ESC guidelines for the management of patients with atrial

fibrillation // Europ. Heart J. - 2001.              - 22. - P. 1852-1923.
  1. Task Force on Sudden Cardiac Death of              the European              Society of              Cardiology              //              Eur.              Heart

J. - 2001. - 22, 16. - P. 1374-1450.
  1. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation // N. Engl. J. Med. - 2002. - 347 (23). - P. 1825-1833.
  2. Thiene G., Nava A., Angelini A. et al. Anatomoclinical aspects of arrhythmogenic right ventricular cardiomyopathy//G. Gamerim, J.F. Goodwin (Eds) Advances in Cardiomyopathies.
  • N. Y., Spring Verlag. - 1990. - P. 397-408.
  1. Van Gelder J., Hagens V., Bosker B. et al. A comparison of rate control and rhythm control in patients with recurrent atrial fibrillation // N. Engl. J. Med. - 2002. - 347 (23). - P. 1834-1840.
  2. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation // Lancet. - 1994. - 343. - P. 687-691.
  3. Wellance H.J. Pullmonary vein ablation in atrial fibrillation: hype or hope // Circulation.
  • 2000. - 102. - P. 2562-2564.
  1. Wetzel U., Hindricks G., Schirdewahn P. et al. A stepwise mapping approach for localization and ablation of ectopic right, left and septal atrial foci using electroanatomic mapping / / Eur. Heart 0. - 2002. - 23, 17. - P. 1388-1394.
  2. Wilde A.A.M., Antzelevitch C., Borggrefe M. et al. Proposed Diagnostic criteria for the Brugada Syndrome // Eur. Heart J. - 2002. - V. 23, 21. - P. 1647-1654.
  3. Wichter Т., Breithardt B.G., Block M. et al. Managment of patients with arrhythmogenic right ventricular cardiomyopathy - results in 127 patients // New Trends Arrhyth. - 1993. - Vol.
  1. № 4. - P. 749-755.
  1. Wood D.A., De Backer G., Faergeman 0., Graham I., Mancia G., Pyorala K. on behalf of the Task Force. Prevention of coronary disease in clinical practice. Recomendations of the second joint Task Force of the European society of Cardiology. European Atherosclerosis Society and European Society of Hypertension // Eur. Heart J. - 1988. - 19. - P. 1434- 1503.
  2. Zuppiroli A. et al. Natural history of mitral valve prolapse // Am. J. CardioL - 1995. - 75. - P. 1028-1031.

предыдущая
к содержанию
следующая

Источник: Мазур Н.А., «ПАРОКСИЗМАЛЬНЫЕ ТАХИКАРДИИ» 2005

А так же в разделе «Литература »